Asbestosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Conditions:   Ovarian Cancer;   Cholangiocarcinoma Recurrent;   Mesothelioma, Malignant Intervention:   Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR Sponsor:   Verismo Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2022 Category: Research Source Type: clinical trials